Current Region: North America
Your selections will be saved and used to recommend products based on your interests.
Oct 23 2014 10:00AM - Oct 24 2014 6:00PM | KFC Hall
CALL FOR ABSTRACTSSubmission Deadline: MAY 12, 2014Author Notification: JUNE 30, 2014To submit an abstract for the DIA Cardiac Safety Workshop, please go click on the DIA Get Involved link.
For inquiries about abstract submission, please contact Keiko Cambridge, Event Planning Managertel: +81-3-5575-2130 Keiko.Cambridge@diajapan.org
Can TQT studies be completely removed from the paradigm? What should an intensive ECG study be? How will the IQ-CRSC prospective study influence the new paradigm? Will the current S7B and E14 guidelines be revised or will new guidelines be drafted?
This is a challenging time. The 5th Cardiac Safety Workshop in Japan will deal with the above and other topics. The program committee is inviting authors to submit abstracts for review, for oral presentation at the main event.
Medipolis Medical Research Institute, CPC Clinical Trial Hospital, Japan
Vice President of CardiologyBioClinica Inc., United Kingdom
Pharmacovigilance DepartmentTaiho Pharmaceutical Co., Ltd., Japan
Director, Clinical Trial CenterKitasato University East Hospital, Japan
Senior Director, Global Medical Affairs-Japan, Takeda Development Center JapanTakeda Pharmaceutical Company Limited, Japan
Senior Scientist for Clinical MedicinePharmaceuticals and Medical Devices Agency (PMDA), Japan
Chairman & Professor of PharmacologyToho University School of Medicine, Japan
Manager, Office of Review ManagementPharmaceuticals and Medical Devices Agency (PMDA), Japan